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Obesity is a major risk factor driving the global type II
diabetes pandemic. However, the molecular factors
linking obesity to disease remain to be elucidated.
Gender differences are apparent in humans and are
also observed in murine models. Here, we link these
differences to expression of eukaryotic translation
initiation factor 4E binding protein 1 (4E-BP1), which,
upon HFD feeding, becomes significantly reduced
in the skeletal muscle and adipose tissue of male
but not female mice. Strikingly, restoring 4E-BP1
expression in male mice protects them against
HFD-induced obesity and insulin resistance. Male
4E-BP1 transgenic mice also exhibit reduced white
adipose tissue accumulation accompanied by
decreased circulating levels of leptin and triglycer-
ides. Importantly, transgenic 4E-BP1 male mice are
also protected from aging-induced obesity and
metabolic decline on a normal diet. These results
demonstrate that 4E-BP1 is a gender-specific sup-
pressor of obesity that regulates insulin sensitivity
and energy metabolism.
INTRODUCTION
White adipose tissue is the major tissue that stores excess
energy and regulates thermogenesis (Tseng et al., 2010; Wu
et al., 2013). In addition, this tissue secretes several adipokines
in the regulation of whole-body metabolic homeostasis and in
response to chronic inflammation, the likely cause of insulin
resistance (Samuel and Shulman, 2012; Tseng et al., 2010;
Zeyda and Stulnig, 2007). Obesity induced by a high-fat diet
(HFD) is associated with increased secretion of adipokines,
such as tumor necrosis factor a and interleukin-6, and contrib-
utes to systemic inflammation and insulin resistance. The con-
nections between obesity, adipokine secretion, and metabolic
dysfunction remain to be understood.Cell Re
This is an open access article under the CC BY-NOf individuals diagnosed with type II diabetes (T2D), nearly
80% are also obese. However, not all obese individuals will
develop T2D (Carnethon et al., 2012; Cowie et al., 2010). Family
history, age, and race all contribute to individual susceptibility to
T2D, suggesting that genetic factors are involved in its onset.
Genetic association studies have pinpointed many risk factors
(Elbein et al., 2012; Lyssenko and Laakso, 2013; Morris et al.,
2012; Williams et al., 2014), but it remains poorly understood
why obesity drives metabolic dysfunction in some but not all
cases.
In rodent models exposed to a HFD, gender dimorphism with
respect to insulin resistance and glucose intolerance has also
been reported (Grove et al., 2010; Macotela et al., 2009).
A HFD induces a similar level of obesity in male and female
mice, but the levels of anti-inflammatory signals are reported
to be higher in female mice (Nickelson et al., 2012; Pettersson
et al., 2012; Stubbins et al., 2012). This increase in anti-inflamma-
tory signaling is correlated with maintenance of insulin sensi-
tivity. The molecular basis for gender dimorphism is not yet fully
understood.
The mammalian target of rapamycin (mTOR) kinase, a prin-
cipal sensor that integrates nutrient levels to cell growth and
proliferation, is a target downstream of insulin signaling (Dazert
and Hall, 2011; Laplante and Sabatini, 2012). mTOR forms
two functional complexes, mTOR complex 1 (mTORC1) and
mTOR complex 2 (mTORC2). Activation of mTORC1 leads to
the phosphorylation of the ribosomal S6 kinases (S6Ks) and
4E-BP (among other targets), which together induce ribosome
biogenesis and mRNA translation (Sonenberg and Hinnebusch,
2009). mTORC1-dependent phosphorylation of 4E-BP results
in dissociation of 4E-BP from eIF4E, specifically promoting
cap-dependent translation initiation. Upregulation of mTORC1
signaling is often observed in tissues of obese individuals and
mice and is associated with progressive insulin resistance
(Cornu et al., 2013; Laplante and Sabatini, 2012). Reduced
mTORC1 activity has been reported to prevent development of
T2D and protect against diabetic nephropathy in both type I
and type II diabetic mouse models (Go¨del et al., 2011; Inoki
et al., 2011; Polak et al., 2008; Um et al., 2004; Yang et al.,
2007). However, the downstream target by which reducedports 16, 1903–1914, August 16, 2016 ª 2016 The Author(s). 1903
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Gender Dimorphism in Diet-Induced Insulin Resistance and Glucose Intolerance in the C57BL/6J Mouse Strain
(A) Body weight measurement in wild-type C57BL/6J male and female mice on a normal chow diet and HFD (n = 20–53). p < 0.001 (NCD versus HFD: males
started at 10 weeks and females started at 12 weeks). p < 0.001 (males versus females: NCD started at week 4). p < 0.001 (males versus females: HFD started at
week 6).
(B) Fat mass measurement normalized with body weight in 6-month-old wild-type C57BL/6J male and female mice on a normal chow diet and HFD.
(C) Glucose tolerance assay in 6 hr-fasting wild-type C57BL/6J male and female mice on a normal chow diet and HFD (n = 36–44). *p < 0.05, **p < 0.001 (NCD
versus HFD: same gender). #p < 0.001 (males versus females: NCD). Up < 0.001 (males versus females: HFD).
(D) Plasma leptin measurement in 6-month-old wild-type C57BL/6J male and female mice on a normal chow diet and HFD. The p values of the cross-comparison
from the other groups were labeled as follows: *p < 0.05, **p < 0.01, ***p < 0.001.
(E) H&E (top) and F4/80 immunohistochemistry (IHC; bottom) staining of the visceral fat from 6-month-old HFD-fed wild-type male and female mice (n = 47 for
each group).
(legend continued on next page)
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mTORC1 activity regulates whole-body metabolic homeostasis
has not been determined.
Previously, 4E-BPs were shown to regulate adipogenesis
and insulin sensitivity, making them strong candidates to link
mTORC1 signaling and metabolism (Le Bacquer et al., 2007;
Tsukiyama-Kohara et al., 2001). Whole-body deletion of 4E-
BP1 and 4E-BP2 yields hypersensitivity to diet-induced obesity
and insulin resistance. Here we report that gender differences
in the expression of 4E-BP1 affect an individual’s response to
a normal and high-fat diet. The expression of 4E-BP1 is reduced
specifically in male but not female skeletal muscle and adipose
tissues on a HFD. This loss of expression has relevance because
transgenic 4E-BP1 expression protects male mice specifically
from diet-induced obesity and insulin resistance. Suppression
of white adipose tissue accumulation is associated with reduced
circulating free fatty acids as well as the secreted hormone leptin
in male 4E-BP1 transgenic mice on a HFD. Similar results were
obtained in aging mice, where 4E-BP1 transgenic expression
protects aging male 4E-BP1 transgenic mice from aging-
induced obesity and metabolic decline. These findings reveal
that a previously unappreciated gender-specific regulation of
4E-BP1 underlies differential responses to overnutrition and
that maintenance of 4E-BP1 function in male mice is important
to offset the detrimental metabolic consequences of obesity.
RESULTS
Gender Dimorphism in a Diet-Induced Insulin
Resistance Mouse Model
We sought to compare and contrast the impact of a HFD on
obesity and metabolic dysfunction in male and female C57BL/
6J mice. Mice from both genders were placed on either a normal
calorie diet (NCD) (18% calories from fat) or a HFD (60% calories
from fat) for 16 weeks beginning at 8 weeks of age. During this
period, HFD-fed male mice gained 60% more weight than the
NCD-fed cohort, whereas HFD-fed female mice gained 50%
more weight than their NCD-fed cohort (Figure 1A). In general,
males accumulated more adipose mass than females on either
diet (Figure S1A), but both males and females had a similar level
of obesity (approximately 38% adiposity) after 16 weeks on a
HFD, as compared to NCD-fed mice (11% adiposity; Figure 1B).
Despite similar levels of obesity, male mice on a HFD had
significantly higher fasting plasma glucose levels (Figure S1B)
and developed more severe glucose intolerance and insulin
resistance compared with female mice (Figure 1C; Figure S1C).
HFD-fed male mice also had markedly increased serum leptin
and triglyceride levels relative to females (Figure 1D; Figure S1D).
In addition, there is a significant increase in macrophage accu-
mulation in HFD-fed male mouse white adipose tissue (Fig-
ure 1E), which is correlated with induced pro-inflammatory
gene expression (Figure 1F). Taken together, these data suggest
that the intrinsic quality of adipose tissue is different in males and(F) Real-time PCR analysis of proinflammatory gene expression in visceral fat fro
induction was normalized to female normal diet-fed samples. The p values of the c
0.01, ***p < 0.001.
All graphs are plotted as mean ± SEM of the number of mice used in each analysis
two-way ANOVA in (B), (D), and (F) and two-way ANOVA for repeated measuresfemales on a HFD. Adipose tissues of HFD-fed male mice have
enhanced secretion of factors that contribute to insulin resis-
tance and glucose intolerance compared with adipose tissue in
HFD-fed females.
Abnormal induction of mTORC1 signaling has been observed
in response to insulin resistance and to be associated with dia-
betes progression (Cornu et al., 2013; Laplante and Sabatini,
2012). Thus, we examined whether the expression pattern of
mTORC1signaling downstream targets correlatewith thegender
dimorphism in diet-induced insulin resistance in C57BL/6J mice.
Previously, upregulation of S6K1 signaling has been observed in
diabetic tissues, and removal of S6K1 in mice has been reported
to yield resistance to diet-induced obesity and insulin resistance
(Umet al., 2004). Consistentwith this phenotypic observation,we
found that a target of S6K1, S6, is constitutively phosphorylated
in both male and female mice on a HFD (Figures S1E and S1F).
Although S6K1 signaling is active in both genders on a HFD,
the mRNA expression and protein level of 4E-BP1 was signifi-
cantly reduced in the skeletal muscle and adipose tissues of
HFD-fed male mice. 4E-BP1 was less affected in females, with
no significant difference in skeletal muscle. The basal level of
4E-BP1 expression is comparable in male and female mice on
a normal diet, so the reduction of 4E-BP1 in male tissues is due
to HFD feeding (Figure 2; Figures S2A–S2E). Although 4E-BP1
protein levels are comparable in female visceral fat between diets
(Figure 2C; Figure S2B), 4E-BP1 protein is highly phosphorylated
in visceral fat of HFD-fed femalemice (FiguresS2DandS2E). The
levels of 4E-BP1mRNA also become reduced in adipose tissues
of HFD-fed female mice (Figure 2A). Phosphorylation of 4E-BP1
at mTORC1-regulated Thr37/46 site is slightly higher in tissues
of HFD-fed mice (Figures S2D and S2E).
Next we examined possible mechanisms underlying sexual
dimorphic regulation of 4E-BP1 expression. The expression of
4E-BP1 has been shown to be repressed by increased in-
flammatory signaling in vitro (Rolli-Derkinderen et al., 2003;
Walsh et al., 2008; Weichhart et al., 2008). Moreover, sexual
dimorphism in the inflammatory response has been reported
in human obese subjects (Bloor and Symonds, 2014; Brown
et al., 2010), in addition to our HFD-fed mice (Figures 1E and
1F). We hypothesized that the increased inflammation upon
HFD feeding might be responsible for the decrease in 4E-BP1
expression. To test this, we treated primary mouse embryonic
fibroblasts (MEFs) with an inflammatory agent, lipopolysaccha-
ride (LPS), to acutely induce inflammation. Associated with the
induction of phosphorylation of JNK, c-Jun N-terminal kinase
(pJNK) signaling, 4E-BP1 is downregulated in LPS-treated
MEFs (Figures S2F and S2G), suggesting that inflammation
could be one of the factors regulating 4E-BP1 expression in dia-
betic tissue. This is consistent with a previous report that upre-
gulation of the pJNK pro-inflammatory signaling pathway can
repress 4E-BP1 expression in a pancreatic b cell line (Tominaga
et al., 2010).m 6-month-old normal diet-fed or HFD-fed male or female mice (n = 4). Fold
ross-comparison from the other groups were labeled as follows: *p < 0.05, **p <
. The numbers of samples analyzed are indicated. p Values were calculated by
in (A) and (C), with Bonferroni post-tests to compare replicate means by row.
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Figure 2. Differential 4E-BP1 Expression in 6-Month-Old C57BL/6J Mice on a HFD
(A) Real-time PCR analysis of 4E-BP1mRNA expression in quadriceps muscle (q. muscle), liver, and visceral fat (v. fat) from normal diet-fed and HFD-fed male
and female mice (n = 4). Fold induction was normalized to male normal diet-fed samples. Results are presented as mean ± SEM. p values were calculated by
two-way ANOVA with Bonferroni post-tests to compare replicate means by row.
(B) Western blot of 4E-BP1 protein expression in quadriceps muscle, liver, and visceral fat from normal diet-fed or HFD-fed male mice.
(C) Western blot of 4E-BP1 protein expression in quadriceps muscle, liver, and visceral fat from normal diet-fed or HFD-fed female mice.Generation and Characterization of 4E-BP1 Transgenic
Mice
Mice lacking 4E-BP1 and 4E-BP2 have increased obesity and
insulin resistance on a HFD. Thus, we hypothesized that 4E-
BPs are required to maintain adipose function in response to a
HFD. To test this, we generated a transgenic mouse line with a
conditional allele overexpressing 4EBP1. The 4EBP1 transgenic
allele (Tg-4EBP1wt) contains a human 4E-BP1 cDNA that was
inserted under a hybrid cytomegalovirus enhancer and chicken
b actin promoter and preceded by a loxP-flanked GFP with a
STOP cassette (Figure S3A). CMV-Cre transgenic mice, which
express Cre during early embryogenesis, were bred with Tg-
4EBP1wt mice to induce 4E-BP1 transgene allele expression in
all tissues, including germ cells (Figure S3B). The transgenic
4E-BP1 protein competes with eIF4E associated with eIF4G
from the translation initiation complex, as analyzed in a 7-meth-
ylguanosine 50-triphosphate (m7GTP) pull-down assay (Figures
S3D and S3E). After germline transmission, the mice were bred
to wild-type C57BL/6J to remove the Cre allele. We then back-1906 Cell Reports 16, 1903–1914, August 16, 2016crossed transgenic mice with whole-body 4E-BP1 overexpres-
sion to the C57BL/6J background for five generations to derive
the 4EBP1wt-OE mouse line for the assays described.
We found that 4E-BP1was expressed at high levels in the skel-
etal muscle and liver of 4EBP1wt-OE mice, with lower levels of
expression in visceral fat (Figure S3B). It is also apparent that
much of the expressed 4E-BP1 is in a phosphorylated state, likely
as a result of mTORC1 activity (Figure S3C). 4EBP1wt-OE mice
are viable and fertile, and there is no obvious phenotype to distin-
guish them from control littermates (Figures S3F–S3H, S4A, and
S4B). These mice also have normal glucose homeostasis, as
examined in glucose tolerance and insulin challenge assays,
even thoughmale4EBP1wt-OEmicehavea lower fastingglucose
level at 6 months of age (Figures S4A and S4B).
Reduced Adiposity in Male 4E-BP1 Transgenic Mice
under HFD Feeding
We then challenged mice with HFD feeding to see whether
4EBP1wt-OE mice are protected from diet-induced obesity.
After 16 weeks of HFD feeding, we found that male 4EBP1wt-OE
mice have a significant reduction both in body weight and adi-
pose accumulation, whereas female 4EBP1-OE mice develop
a similar level of obesity as controls (Figures 3A and 3B; Figures
S4C–S4G). Although male control mice gain 60% more weight
than the NCD-fed control cohort, 4EBP1wt-OE male mice only
gain 19% more weight than their NCD-fed counterparts. More-
over, male 4EBP1wt-OE mice also show less food intake than
control counterparts on a HFD (Figure S4H). The difference in
weight gain in HFD-fed 4EBP1wt-OE and control male mice is
mainly attributable to less fat accumulation (Figure S4C). Consis-
tent with reduced obesity, male 4EBP1wt-OE mice also have
lower levels of serum leptin and triglycerides compared with
control mice on a HFD (Figure 3C; Figure S4D).
Histological analysis of WT and 4EBP1wt-OE adipose tissues
clearly revealed a reduction in adiposity in male 4EBP1wt-OE
mice, with decreased white adipocyte accumulation and
reduced adipocyte size (Figures S4E, S4F, and S5A). There
was less accumulated white adipose tissue under the skin
(subcutaneous fat) and also less white fat infiltration into
brown adipose tissue; the latter is consistent with modestly
increased UCP1 expression in brown adipose tissue of HFD-
fed 4EBP1wt-OE male mice (Figure S4G). Moreover, there was
decreased macrophage accumulation, as stained by F4/80 anti-
gen, in visceral fat of male 4EBP1wt-OE mice, which correlated
with a reduced level of IL-6 in serum of male 4EBP1wt-OE mice
(Figures S4I and S5A). Morbid obesity usually causes aberrant
accumulation of triglycerides in the liver, which leads to hepatic
steatosis and further impairs systemic fat metabolism. However,
4EBP1wt-OE male mice, as determined by oil red O staining,
clearly demonstrated a significant reduction of accumulated tri-
glycerides in the liver on a HFD, indicative of improved systemic
fat metabolism in these mice (Figure S5A).
Maintenance of Insulin Sensitivity in Male 4E-BP1
Transgenic Mice under HFD Feeding
After 16 weeks of HFD feeding, both control male and female
mice developed hyperglycemia. Fasting glucose was also
elevated in 4EBP1wt-OE male mice on HFD feeding but to a
lesser extent than in non-transgenic control male mice (Fig-
ure 3D). Next we examined glucose homeostasis in 4EBP1wt-OE
mice. A glucose tolerance assaywas performed to determine the
ability of the mice to sense glucose elevation and secrete insulin
as a means of promoting blood glucose uptake in peripheral
tissues. Male 4EBP1wt-OE mice display improved glucose ho-
meostasis on a HFD, as demonstrated by improved glucose
clearance relative to controls (Figure 3E). An insulin challenge
assaywas also performed to quantify systemic insulin resistance
in mice on a HFD. The reduction of blood glucose levels was
faster in male 4EBP1wt-OE mice than in control mice over the
course of the experiment (Figures S4K and S4L), with compara-
ble insulin levels (Figure S4J). Furthermore, tissue of male
4EBP1wt-OE mice maintained insulin-stimulated Akt phosphor-
ylation (Figure 3F; Figure S5C–S5F).
Previously, we identified increased FGF21 signaling in a
different line of 4E-BP1 transgenic mice that express in skeletal
muscle a 4E-BP1 mutant allele resistant to mTORC1 regulation
and demonstrated that these mice were also protected fromHFD-induced obesity and insulin resistance (Tsai et al.,
2015). The expression of FGF21 is also upregulated in male
4EBP1wt-OEmice but, this time, in liver tissue (Figure S5B), sug-
gesting that the levels of FGF21 and 4E-BP1 are positively asso-
ciated. Another prospective mechanism in 4EBP1wt-OE mice
protected from HFD-induced metabolic dysfunction is through
competing mTORC1 phosphorylating S6K1. However, we did
not observe an alternation of phosphorylation status on either
S6K1 or its target rpS6 under HFD feeding in multiple tissues
of male 4EBP1wt-OE mice (Figures S6A and S6B).
Among other mTORC1 targets examined in the HFD cohort,
the phosphorylation of PRAS40, the proline-rich Akt substrate,
by mTORC1 on Ser183 is increased in male mouse visceral
fat upon HFD treatment (Figure S6C). Phosphorylation of
PRAS40 at Ser183 by mTORC1 has been reported to suppress
its ability to inhibit mTORC1 in vitro (Oshiro et al., 2007; Wang
et al., 2008). The level of PRAS40 phosphorylation at Ser183
was reduced in fat tissue of mice overexpressing 4E-BP1,
although the trend did not reach significance (Figure S6D).
The repression of PRAS40 phosphorylation in male 4EBP1wt-
OE mice is more profound in visceral fat during aging, as dis-
cussed in more detail below (Figure S9A). Previously, DEPTOR,
another mTOR-interacting protein, has been shown to positively
regulate adipogenesis in vitro, and its expression is associated
with obesity in vivo (Laplante et al., 2012). The changes of
DEPTOR expression were not evident in HFD-treated mouse
tissues (Figure S6E), but there is a slight induction of DEPTOR
expression in the visceral fat of male 4EBP1wt-OE mice (Fig-
ure S6F). In the context of overnutrition, male 4EBP1wt-OE
mice have improved glucose tolerance and increased insulin
sensitivity on a HFD. Mechanistically, the improved metabolic
function might occur through induction of FGF21 production
in male 4EBP1wt-OE mice.
Tissue-Specific Induction of 4E-BP1 in Adipose or
Skeletal Muscle Does Not Provide Metabolic Protection
in Mice on a HFD
Because4E-BP1expression ispredominately reduced in adipose
tissueandskeletalmuscleuponHFD,wecrossedTg-4EBP1mice
witheitherFabp4-Cre (Tg-4EBP1wt;Fabp4-Cre, referred toasTg-
4EBP1wt-fat) orCkmm-Cre (Tg-4EBP1wt;Ckmm-Cre, referred to
as Tg-4EBP1wt-muscle) mice to remove the loxP-flanked GFP-
STOP codon cassette and promote 4E-BP1 transgene allele
expression in mouse adipose tissue or skeletal muscle, respec-
tively (Figures S7A and S7B). This approach was designed to
determine whether 4E-BP1 activity is required to achieve protec-
tion from a HFD challenge. Both transgenic mouse lines were
backcrossed to the C57BL/6J background for five generations
prior to their characterization.
Both Tg-4EBP1wt-fat and Tg-4EBP1wt-muscle mice have
comparable body weight, adiposity, lean body mass, and
glucose metabolism in comparison with control littermates (Fig-
ure 4; Figures S7C–S7E). We subjected both transgenic mouse
lines to a HFD challenge starting at 8 weeks of age and moni-
tored their weight and glucose metabolism during the course
of 16 weeks. Neither Tg-4EBP1wt-fat nor Tg-4EBP1wt-muscle
mice of either gender show any metabolic protection from
HFD-induced obesity and insulin resistance (Figure 4; FiguresCell Reports 16, 1903–1914, August 16, 2016 1907
Figure 3. Male 4EBP1-OE Transgenic Mice Are Protected from Diet-Induced Obesity and Maintain Insulin Sensitivity
(A) Body weight measurement in 4EBP1-OE transgenic and wild-type mice on a HFD (n = 7–9). p < 0.001 (WT versus 4EBP1-OE: males started at week 10).
p < 0.001 (males versus females: WT started at week 8). p < 0.001 (males versus females: 4EBP1-OE started at 8 weeks]. Male 4EBP1-OE versus female WT,
p < 0.01 at weeks 8–14, p < 0.001 at weeks 16–18, and p < 0.05 at week 20. p < 0.001 (male WT versus female 4EBP1-OE started at week 6).
(B) Adiposity measurement in 6-month-old 4EBP1-OE transgenic and wild-type mice on a HFD.
(C). Plasma leptin measurement in 4EBP1-OE transgenic and wild-type mice on a HFD at 6 months of age.
(D) Plasma glucose measurement in 6 hr-fasting 4EBP1-OE transgenic and wild-type mice on a HFD at 6 months of age.
(E) Glucose tolerance assay in 6 hr-fasting 4EBP1-OE transgenic and wild-type mice on a HFD at 6 months of age (n = 9). *p < 0.05, **p < 0.001 (WT versus
4EBP1wt-OE: male). #p < 0.001 (male versus female: WT).
(F) Western blot of phosphorylation of AKT1 at Ser473 and total AKT1 protein expression in visceral fat of 4EBP1-OE transgenic and wild-type male mice before
() or after (+) insulin stimulation on a normal chow diet or HFD at 6 months of age.
All graphs are plotted as mean ± SEM of the number of mice used in each analysis. The numbers of samples analyzed are indicated. p Values were calculated by
two-way ANOVA in (B–D) and two-way ANOVA for repeatedmeasures in (A) and (E), with Bonferroni post-tests to compare replicatemeans by row. For simplicity,
in (B–D), the p values of the cross-comparison from the other groups was labeled as follows: *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 4. Assessment of Metabolic Parameters in 4E-BP1 Double-Transgenic Male Mice
(A) Body weight measurement in Tg-4EBP1wt-fat and Tg-4EBp1wt-muscle male mice on a normal chow diet and HFD (n = 8–16). p < 0.001 (NCD versus HFD:
males started at 10 weeks).
(B) Glucose tolerance assay in 6 hr-fasting Tg-4EBP1wt-fat and Tg-4EBp1wt-muscle male mice on a normal chow diet and HFD at 6 months of age (n = 8–16).
p < 0.001 (NCD versus HFD in all genetic group comparisons: males started at the 30-min time point).
(C) Fat mass measurement normalized with body weight in Tg-4EBP1wt-fat and Tg-4EBp1wt-muscle mice on a normal chow diet and HFD at 6 months of age
(n = 8–16). p < 0.001 (NCD versus HFD in all genetic and gender group comparisons).
(D) Insulin challenge assay in 6 hr-fasting Tg-4EBP1wt-fat and Tg-4EBp1wt-muscle male mice on a HFD at 6 months of age (n = 8–16).
All graphs are plotted as mean ± SEM of the number of mice used in each analysis. The number of samples analyzed is indicated. p Values were calculated by
two-way ANOVA (C) and two-way ANOVA for repeated measures (B) and (D) with Bonferroni post-tests to compare replicate means by row.S7C–S7F). The 4E-BP1 transgenic allele encodes a wild-
type 4E-BP1 protein that retains regulation by mTORC1-depen-
dent phosphorylation. Thus, increased mTORC1 signaling on a
HFD may partially or fully inactivate transgenic overexpressed
4E-BP1 protein, preventing any observed metabolic protection
in these transgenic mice. Consistent with this prediction, we
observed an increase in 4E-BP1 phosphorylation in both trans-
genic mouse tissues (Figures S7G and S7H). These findings
suggest that the protection conferred by whole-body overex-
pression of 4E-BP1 cannot be recapitulated by overexpression
specifically in muscle or fat. The benefits must derive from
expression in another tissue or a combination of tissues.Male 4E-BP1 Transgenic Mice Are Protected from
Aging-Induced Obesity and Metabolic Rate Decline
Both male and female 4EBP1wt-OE mice were leaner than con-
trols during aging, but the difference was more pronounced in
male transgenic mice, which showed significantly reduced
adiposity starting at approximately 1 year of age (Figures 5A
and 5B; Figure S8A). Male 4EBP1wt-OE mice also have signifi-
cantly reduced levels of serum leptin and triglycerides along
with reduced adiposity (Figures S8B and S8C). These differ-
ences are not the result of altered food intake or activity (Figures
S8D and S8E). There is also no change in respiratory exchange
ratio in 4EBP1wt-OE mice (Figure S8F). Nevertheless, maleCell Reports 16, 1903–1914, August 16, 2016 1909
Figure 5. Metabolic Parameters of Aging 4EBP1-OE Transgenic and Wild-Type Mice on a Normal Chow Diet
(A) Body weight measurement in 4EBP1-OE transgenic and wild-type mice on a normal chow diet. p < 0.001 (males versus females: WT). p < 0.001 (males versus
females: 4EBP1-OE). Male 4EBP1-OE versus female WT, p < 0.01 at 6 months. p < 0.001 (male WT versus female 4EBP1-OE).
(B) Fat weight measurement in 4EBP1-OE transgenic and wild-type mice on a normal chow diet during aging.
(C) Oxygen consumption in 4EBP1-OE transgenic and wild-type mice on a normal chow diet at 6 months of age. p < 0.001 (males versus females: WT), p < 0.001
(male WT versus female 4EBP1-OE), p < 0.001 (male 4EBP1-OE versus female), p < 0.001 (male WT versus female 4EBP1-OE).
(D) Oxygen consumption in 4EBP1-OE transgenic and wild-type mice on a normal chow diet at 20 months of age. p < 0.01 (males versus females: WT), p < 0.001
(male WT versus female 4EBP1-OE).
All graphs are plotted as mean ± SEM of the number of mice used in each analysis. The numbers of samples analyzed are indicated. p Values were calculated by
two-way ANOVA with Bonferroni post-tests to compare replicate means by row. *p < 0.05, **p < 0.01, ***p < 0.001.4EBP1wt-OEmice have an increased metabolic rate (Figures 5C
and 5D) that is evident as early as 6 months of age, when their
body weight is comparable with control littermates (Figure 5A).
Consistent with the HFD cohort, no difference was observed in
S6K1 phosphorylation or its downstream target rpS6 (Figures
S8G and S8H). The protein stability of IRS1, insulin receptor sub-
strate 1, is affected by serine phosphorylation by either S6K1 at
Ser307 or mTORC1 at Ser636/639 and has been proposed to
lead to insulin resistance (Copps and White, 2012; Um et al.,
2006). Consistent with the lack of alteration of S6K1 phosphory-
lation, we also failed to observe any significant changes in serine
phosphorylation of IRS1 or IRS1 stability (Figure S8I; data not
shown). Moreover, there is no reduction of global translation in
4EBP1wt-OE mouse tissues (Figure S8J).1910 Cell Reports 16, 1903–1914, August 16, 2016Mice develop a comparable level of obesity during the course
of a 22-month aging study and a 4-month HFD feeding study
(Figure S8K). We found that there is a trend toward reduction
in PRAS40 phosphorylation seen in HFD-fed 4EBP1wt-OE
male visceral fat (Figure S6D), and the reduction in PRAS40
phosphorylation is more profound during aging in the same tis-
sue (Figure S9A).
We also observed a higher level of FGF21 (Figure S9B) in
4EBP1wt-OE male mouse serum, likely associated with protec-
tion of brown adipose during aging (Figure S9C) and higher levels
of Ucp1 and Pgc1a expression in brown adipose tissue of aged
4EBP1wt-OEmale mice (Figure S9E). There is a slight upregula-
tion in mRNA levels of genes involved in thermogenesis in sub-
cutaneous white adipose tissues of 4EBP1wt-OE male mice
Figure 6. Gender Dimorphism in Expression of 4E-BP1 and Activity of S6K1 in Aging C57BL/6J Mice
(A) Macrophage infiltration in visceral fat stained by F4/80 IHC from 6-month-old or 24-month-old wild-type male and female mice (n = 4 for the 6-month-old
cohort and n = 7 for the 24-month-old cohort).
(B) Real-time PCR analysis of proinflammatory gene expression in visceral fat from 6-month-old or 24-month-old wild-type male or female mice (n = 8 for the
6-month-old cohort and n = 7 for the 24-month-old cohort). Fold induction was normalized to 6-month-old female samples.
(C) Quantification of the western blot of 4E-BP1expression normalized with the housekeeping gene HSP90 relative to 6-month-old samples.
(D) Quantification of the western blot of phosphorylated S6K1 at Thr389 normalized with total S6K1 expression relative to 6-month-old samples.
Youngmouse cohorts were from 6-month-oldmice, and oldmouse cohorts were from 24-month-oldmice. All graphs are plotted asmean ±SEMof the number of
mice used in each analysis. p Values were calculated by two-way ANOVA with Bonferroni post-tests to compare replicate means by row.(Figure S9D). Moreover, male 4EBP1wt-OE mice have reduced
muscle damage during aging, including lower numbers of
centralized, vacuolated fibers, and decreased intramuscular
fatty acid accumulation (Figures S9F and S9G).
In a further analysis of aging tissues, we found a similar nega-
tive correlation of inflammation and 4E-BP1 expression as in the
HFD cohort (Figures 1E, 1F, and 2). The increased macrophage
infiltration and induced pro-inflammatory cytokine gene expres-
sion (Figures 6A and 6B) is associated with reduced 4E-BP1
expression in visceral fat of both aging male and female mice
(Figure 6C). Consistent with this notion, whole-body overexpres-
sion of 4E-BP1 protected both males and females from aging-
induced obesity (Figure 5B). Moreover, there is a gender
difference in the expression of the mTORC1 targets S6K1 and
4E-BP1 in aging tissues. 4E-BP1 is selectively reduced in maleliver and visceral fat, whereas phosphorylation of S6K1, or its
target S6, is exclusively upregulated in aging female tissues (Fig-
ures 6C and 6D; Figure S10). The distinct expression pattern of
4E-BP1 and S6K1 in aging mouse tissues could be the reason
why only female s6k1 knockout mice have a lifespan extension
(Selman et al., 2009) and male 4EBP1wt-OE mice are protected
from aging-induced metabolic decline.
DISCUSSION
Here, we report a gender-dependent divergence in 4E-BP1
expression and its effect on metabolic regulation in response
to different diets. With a HFD challenge, 4E-BP1 expression is
significantly reduced in male skeletal muscle and adipose tissue.
Male and female mice develop a similar level of obesity on aCell Reports 16, 1903–1914, August 16, 2016 1911
HFD, but male mice have aggravated and deregulated lipid and
glucose metabolism. Furthermore, increased expression of 4E-
BP1 rescues male mice from diet-induced obesity and insulin
resistance, whereas 4E-BP1 overexpression does not provide
beneficial protection to HFD-fed female mice.
In the context of aging, we found that expression of 4E-BP1
is selectively downregulated in aging male mouse liver and
adipose tissue. Overexpression of 4E-BP1 protects male mice
from aging-induced obesity and increases energy expenditure.
Conversely, we observed enhanced upregulation of S6K1 activ-
ity in aging female liver, skeletal muscle, and adipose tissues.
The sexual-dimorphic regulation of two mTORC1 targets,
S6K1 and 4E-BP1, correlates with the enhanced lifespan of fe-
male s6k1 knockout mice and improved metabolic homeostasis
in male 4EBP1wt-OE mice during aging. Recently, Baar et al.
(2016) reported that there is variation in mTORC1 signaling dur-
ing aging of C57BL/6J mice. S6K1 was upregulated in adipose
tissues of fasted male and female mice and skeletal muscle
tissues of male mice, and there was no difference in 4E-BP1
expression. The differences between these two studies in the
assessment of mTORC1 signaling from aging tissues could be
due to the nutrition status of the mice at the time they were har-
vested because the mTOR pathway is highly sensitive to calorie
intake. We harvested mice in the morning after they had ad libi-
tum access to food during the evening, whereas Baar et al.
(2016) harvested mice after overnight fasting. Further studies
will be required to explain how nutrition and aging intersect to in-
fluencemTOR signaling. Adipose tissue plays a central role in the
management of whole-body energy expenditure, regulating both
glucose homeostasis and insulin sensitivity (Bl€uher et al., 2003).
Altered mTORC1 signaling is implicated in obese human and
animal adipose tissues. Specific deletion of mTORC1 in adipose
tissue or whole-body inactivation of its downstream mediator,
S6K1, in mice leads to reduced adiposity and increased meta-
bolic rate. Both mice were also protected from HFD-induced
obesity and insulin resistance (Polak et al., 2008; Um et al.,
2004). Conversely, whole-body inactivation of 4E-BP1 and
4E-BP2, which are negatively regulated by mTORC1, results in
increased adiposity and sensitivity to HFD-induced metabolic
dysfunction (Le Bacquer et al., 2007). Previous studies did not
examine the mTORC1 pathway for gender-specific effects.
Here we have demonstrated that mTORC1 signaling behaves
differently in male and female mice via 4E-BP1. A HFD preferen-
tially suppresses 4E-BP1 expression in male adipose tissues,
which is correlated with increased adiposity and adipokine
secretion. Overexpression of 4E-BP1 reverses these defects.
The molecular mechanism underlying how 4E-BP1 expression
is differentially regulated by gender is not clear. One likely expla-
nation involves sexual dimorphic regulation of inflammation,
which, in turn, regulates 4E-BP1 expression.
Gender differences in the intrinsic characteristics of adipose
tissue and the subsequent response to overnutrition have been
reported (Macotela et al., 2009; Nickelson et al., 2012; Petters-
son et al., 2012). For example, despite the higher level of body
fat, female humans and rodents are more insulin-sensitive than
males. During overnutrition in humans and rodents, male sub-
jects have increased adipokine secretion, which contributes to
inflammation and early abnormalities of glucose metabolism.1912 Cell Reports 16, 1903–1914, August 16, 2016The mechanism underlying this phenomenon is in part due to
the action of estrogen and testosterone. For example, females
after menopause exhibit higher risk for the development of insu-
lin resistance, and castrated male rodents are more insulin-sen-
sitive (Mauvais-Jarvis et al., 2013). Hormonal regulation could
also contribute to sex-specific regulation of 4E-BP1 expression.
It remains unclear in which tissues 4E-BP1 is regulated in a
gender-specific manner during overnutrition and aging and
where overexpression of 4E-BP1 rescues metabolic dysfunction
in males. Recently, we reported that transgenic expression of
activated, mTORC1-non-responsive 4E-BP1 in skeletal muscle,
but not adipose tissue, protects mice of both genders from high
fat diet-induced metabolic dysfunction (Tsai et al., 2015).
Because activated 4E-BP1 is refractory to the elevatedmTORC1
signaling associated with exposure to a high-fat diet, one possi-
bility is that the primary benefits of 4E-BP1 activation are in
skeletal muscle. A small increase in 4E-BP1 activity when the
wild-type protein is overexpressed might only be sufficient to
suppress defects associated with loss of 4E-BP1 in male mice
during a high-fat diet or aging. Higher skeletal muscle activity
in the 4E-BP1 mutant may increase metabolic protection in
both genders under the same challenges. Alternatively, the phe-
notypes associated with whole-body overexpression of wild-
type 4E-BP1 may derive from enhanced activity in other tissues.
Further studies will be required to resolve this issue.
Our results demonstrate that 4E-BP1 expression in adipose
and skeletal muscle tissue is a key determining factor in the
gender dimorphism of fat metabolism and insulin sensitivity. In
addition, they provide genetic evidence for gender differences
in the response to overexpression of 4E-BP1 in obesity. Hence,
our findings have important implications for the treatment of
metabolic syndrome, obesity, and T2D because gender differ-
ences in the response to drugs targeting the mTORC1 pathway
may exist in humans.
EXPERIMENTAL PROCEDURES
Generation of 4E-BP1 Transgenic Mice and Animals Studies
Human 4E-BP1 cDNA was placed downstream of a loxP-GFP-3xstop-loxP
cassette under the control of a chicken b-actin promoter. The GFP-STOP
cassette prevents expression of the 4E-BP1 transgenic allele. Transgenic
mice were then crossed with mice expressing CRE under the control of a
human cytomegalovirus minimal promoter (CMV-Cre) to induce whole-body
4E-BP1 transgene expression, fatty acid-binding protein 4 promoter (Fabp4-
Cre) to induce adipose tissue 4E-BP1 transgene expression, or the muscle
creatine kinase promoter (Ckmm-Cre) to induce skeletal muscle tissue 4E-
BP1 transgene expression. All mice in this study were five generations into
the C57BL6/J background. In the high-fat diet-induced type II diabetes study,
mice at 8 weeks of age were placed on either a standard laboratory rodent
chow (#2018, Harlan Teklad) or a high-fat diet (D12492, Research Diets), as
indicated, and monitored for 24 weeks. Mice were handled in accordance
with, and all in vivo studies were approved by, the Institutional Animal Care
and Use Committee (A10093) at the Buck Institute for Research on Aging.
Histological Analysis
Tissue samples were either fixed in 4% paraformaldehyde solution in PBS
before being embedded in paraffin or directly mounted in optimal cutting tem-
perature compound (OCT) before being stored at 80C. Morphology was
examined in H&E-stained sections. The size of adipose cells was quantified
in ImageJ. Results are shown as amean ± SEM of three to six independent an-
imals. The oil red O staining was performed in OCT-mounted liver sections and
flash-frozen muscle tissue sections. 10-mm-thick sections were cut and al-
lowed to dry for 10 min. After the air-drying process, the slides were rinsed
for a short time in distilled water and stained in 300 mg/dl oil red O solution
in isopropanol for 15min. The slides were then transferred to 60% isopropanol
to clean the background and resin in distilled water and processed for hema-
toxylin counterstaining. Macrophage infiltration of white adipose tissue was
stained using monoclonal F4/80 antibody (Invitrogen) on paraffin sections.
Blood Lipid, Glucose, and Hormone Analyses
Mouse blood was collected using the submandibular pouch technique. Serum
was separated using serum separator tubes (BD 365956). The analyses of tri-
glyceride, FGF21, insulin, and leptin levels were performed in sera collected
from mice that were fasted for 6 hr. The IL-6 assay was performed on serum
from non-fasted mice. The triglyceride test (2100-430) was purchased from
Stanbio, the analysis of FGF21 (MF2100) and IL-6 (M6000B) ELISA was pur-
chased from R&D Systems, the analysis of insulin (NR 10-1247-01) ELISA
was purchased fromMercodia, and all were performed following themanufac-
turer’s instructions. The leptin tests were done in the Diabetes, Endocrinology,
and Metabolism Hormone Assay and Analytical Services Core at Vanderbilt
University.
Glucose and Insulin Tolerance Assays
Glucose and insulin tolerance tests were performed on 6-month-old mice that
were fasted for 6 hr. Glucose concentrations were determined with an Accu-
Chek advantage glucometer (Roche) in blood collected from the tail vein at
indicated time points. Insulin (0.75 U/kg for HFD group mice and 0.375 U/kg
for NCD group mice) or glucose (2 g/kg) was injected intraperitoneally into
mice. Insulin was Humulin R (U-100) from Lilly.
RNA Analyses
Total RNA was extracted from tissue using Trizol (Life Technologies) following
the manufacturer’s instructions (n = 4 for each group, 6-month-old mice). 2 mg
of total RNA was reverse-transcribed into cDNA by using the Superscript III
reverse transcription kit (Invitrogen). Real-time PCR was performed in a
Roche 480 iCycler PCR machine. Reactions were performed in triplicate,
and relative amounts of cDNA were normalized to Cyclophilin A (Ppia). Primer
sequences were as follows: 4E-BP1 forward, CTAGCCCTACCAGCGATGAG;
4E-BP1 reverse, CCTGGTATGAGGCCTGAATG; Ppia forward, GACCAAACA
CAAACGGTTCC; Ppia reverse, CATGCCTTCTTTCACCTTCC; IL-6 forward,
CCGGAGAGGAGACTTCACAG; IL-6 reverse, TTCTGCAAGTGCATCATCGT;
Ccl-2 forward, CCCAATGAGTAGGCTGGAGA; Ccl-2 reverse, TCTGGACC
CATTCCTTCTTG. Ucp-1 forward, GCCTGGCAGATATCATCACC; Ucp-1
reverse, CAGACCGCTGTACAGTTTCG; Pgc-1a forward, AACCACACCCA
CAGGATCAGA; Pgc-1a reverse, TCTTCGCTTTATTGCTCCATGA; Cidea
forward, CTCGGCTGTCTCAATGTCAA; Cidea reverse, GGAACTGTCCCGT
CATCTGT; Dio2 forward, GCTGTGTCTGGAACAGCTTC; Dio2 reverse,
TGAACCAAAGTTGACCACCA; Prdm16 forward, GAGCAGCTGAGGAAG
CATTT; Prdm16 reverse, GCGTGGAGAGGAGTGTCTTC; Stat6 forward,
CTGCCTAACTCAGCCTGTGG;Stat6 reverse, CCTGATTGCCCATAAGGAGA.
Protein Isolation and Immunoblotting Studies
Tissues were homogenized in cold SDS lysis buffer (50 mM Tris [pH 7.5],
70 mM urea, 250 mM sucrose, and 2% SDS) with protease inhibitor cocktail
(Roche, 04693124001) and phosphatase inhibitor cocktails II and III (Sigma,
P5726 and P0044). Total proteins were separated in 4%–12% Invitrogen BT
precast gel (NP0315) or any KD Bio-Rad TGX precast gel (456-9033) and
transferred to nitrocellulose membranes. Antibodies were from Cell Signaling
Technology (a-4E-BP1 [#9252], a-phospho-4EBP1 Ser65 [#9451], a-phos-
pho-4EBP1 Thr37/46 [#9459], a-S6 [#2217], a-phospho-S6 Ser235/236
[#2211], a-AKT1 [#4691], a-phospho-AKT Ser473 [#4060], a-JNK [#9258],
a-phospho-JNK Thr183/Tyr185 [#9251], a-eIF4E [#2067], a-eIF4G [#2469],
a-S6K1 [#2708], a-phospho-S6K1 Thr389 [#9234], a-PRAS40 [#2691],
a-phospho-PRAS40 Ser183 [#5936], a-IRS1 [#3015], a-phospho-IRS1
Ser636/639 [#2388], a-HSP90 [#4877], a-atubulin [#3873], and a-b ACTIN
[#4967]), Abcam (a-FGF21 [ab171941] and a-UCP1 [ab23841]), and EMDMilli-
pore (a-DEPTOR, ABS222).Indirect Calorimetric Studies
Oxygen consumption, CO2 production, home activity, and food were
measured by open-flow respirometry (Sable Systems).
Statistics
Unless otherwise stated, all results are expressed as mean ± SEM of n obser-
vations. Statistical differences between the means were assessed by two-way
ANOVA, and all glucose tolerance assays and insulin challenge assays were
analyzed by two-way ANOVA for repeated measures. Bonferroni post-tests
were used to compare replicate means by row.
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